Bausch Health Companies Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Thomas J. Appio (CEO) and Jean-Jacques Charhon (CFO) signed standard Sarbanes-Oxley Section 302 and 906 certifications dated July 30, 2026 for the Q2 2026 10-Q (quarter ended June 30, 2026). Certifications attest that financial statements fairly present the company's condition and operations, disclosure controls are effective, and no material weaknesses or fraud were identified. No operational changes, financial results, or material events are disclosed in these exhibits.
Why this rating
Routine executive certifications required by law; no new operational, financial, or strategic information disclosed.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.